相关实验视频
Updated: Jan 14, 2026

07:47
Measuring Delay Discounting in Humans Using an Adjusting Amount Task
Published on: January 9, 2016
16.0K
多巴胺和时间折扣:回顾药理学和个体差异
Elke Smith1, Hendrik Theis2,3, Thilo van Eimeren2,3
1Department of Psychology, Biological Psychology, University of Cologne, Cologne 50969, Germany e.smith@uni-koeln.de.
概括
多巴胺前体l-DOPA可靠地减少了健康个体的时间折扣,挑战了以前的发现. 多巴胺信号传递中的个体差异并没有显著影响这些时间折扣效应.
科学领域:
- 神经科学是一个神经科学.
- 行为经济学是一种行为经济学.
背景情况:
- 多巴胺 (DA) 神经传递变化与奖励的时间折扣变化有关.
- 以前的研究表明,多巴胺操纵对时间折扣的影响不一致,可能是由于个体差异或样本小.
研究的目的:
- 调查多巴胺前体l-DOPA对大量健康参与者的时间折扣的影响.
- 检查假定多巴胺 (DA) 代理措施是否解释药物对时间折扣影响的个体差异.
主要方法:
- 这是一项随机,双盲,安慰剂控制的研究,涉及76名健康参与者.
- 使用计算建模 (层次贝叶斯参数估计) 管理l-DOPA并评估时间折扣.
- 评估了几种假定的多巴胺代理措施.
主要成果:
- 较高奖励的折扣较小 (幅度效应),复制了先前的发现.
- l-DOPA显著降低了时间折扣率,其效果规模很小.
- 没有可信的证据支持假定多巴胺代理措施在解释个体差异方面的作用.
结论:
- l-DOPA可靠地减少了健康个体的时间折扣,澄清了以前的不一致性.
- 假定的多巴胺代理措施似乎无法解释多巴胺药物对时间折扣的影响的个体变化.
相关概念视频
Timing and Consequences on Behavior
352
In operant conditioning, the timing of reinforcement is crucial. For animals like rats and cats, immediate reinforcement (within a few seconds) is much more effective than delayed reinforcement. For example, a food reward for a rat needs to follow within 30 seconds of pressing a bar to be effective.
Humans, however, can respond to delayed reinforcers. We often make decisions between immediate small rewards and delayed larger rewards. This ability to delay gratification is a significant...
Humans, however, can respond to delayed reinforcers. We often make decisions between immediate small rewards and delayed larger rewards. This ability to delay gratification is a significant...
352
Drug Abuse and Addiction: Pharmacological Phenomena
1.1K
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
1.1K
Drugs Affecting Neurotransmitter Synthesis
2.1K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.1K
Attention-Deficit/Hyperactivity Disorder
743
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
743
Drugs Affecting Neurotransmitter Release or Uptake
1.5K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.5K

